Quantification of EV-associated miRNA in liquid biopsies for biomarker signature development
Mia S. C. Yu , Christian Grätz , Dapi Menglin Chiang , Olivier Loudig , Yadong Zheng , Cole Hladik , Bethany Hannafon , Navneet Dogra , Benedikt Kirchner , Michael W. Pfaffl
Extracellular Vesicles and Circulating Nucleic Acids ›› 2026, Vol. 7 ›› Issue (2) : 833 -72.
Extracellular vesicle (EV)-associated microRNAs (miRNAs) are promising minimally invasive biomarkers, as EV encapsulation protects miRNAs from degradation while preserving disease- and cell- type-specific expression patterns across diverse human body fluids. This review summarizes the current understanding of miRNA and EV biogenesis, including the mechanisms governing EV cargo packaging. We further discuss the broad range of EV sources used in liquid biopsy and molecular diagnostics, including blood, urine, saliva, milk, respiratory fluids, and cerebrospinal fluid, highlighting both the diagnostic utility and key pre-analytical challenges associated with EV-miRNA analysis. State-of-the-art EV isolation approaches, including differential ultracentrifugation, size-exclusion chromatography, affinity-based methods, microfluidic platforms, flow cytometry and nanoparticle-based analyses are not isolation methods and are therefore excluded from this comparison. In addition, workflows for EV-associated RNA extraction and quantification, including RNA sequencing and reverse transcription-quantitative polymerase chain reaction-based methodologies, are critically evaluated. Emphasis is placed on challenges related to data quality assessment, normalization strategies, low-input sample analysis, and high sample heterogeneity. This review also summarizes current standardization initiatives, including MISEV, MIQE, EV-TRACK, and EV Task Force biofluid guidelines, emphasizing the importance of rigorous reporting standards, harmonized pre-analytical workflows, and multiparametric normalization strategies for reproducible detection and accurate quantification. Finally, we discuss emerging best practices and unresolved challenges in multivariate modeling, miRNA isoform-based analyses, and in silico validation of the target recognition elements and regulatory pathways. An integrated, guideline-based workflow from liquid biopsy collection to clinically actionable EV-miRNA signatures is proposed to facilitate translation of this approach into routine molecular diagnostics.
miRNA / extracellular vesicles / biomarker / liquid biopsy / molecular diagnostics
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
Nobel Prize in Physiology or Medicine 2024. Available from: https://www.nobelprize.org/prizes/medicine/2024/summary/. [Last accessed on 28 May 2026] |
| [9] |
|
| [10] |
Bofill-De Ros X, Vang Ørom UA. Recent progress in miRNA biogenesis and decay.RNA Biol2024;21:1-8 PMCID:PMC10761092 |
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
Berumen Sánchez G, Bunn KE, Pua HH, Rafat M. Extracellular vesicles: mediators of intercellular communication in tissue injury and disease.Cell Commun Signal2021;19:104 PMCID:PMC8520651 |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles.Nat Rev Mol Cell Biol2018;19:213-28 |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
Nolte-'t Hoen EN, Buermans HP, Waasdorp M, Stoorvogel W, Wauben MH, 't Hoen PA. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions.Nucleic Acids Res2012;40:9272-85 PMCID:PMC3467056 |
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
Welsh JA, Goberdhan DCI, O’Driscoll L, et al.; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches.J Extracell Vesicles2024;13:e12404 PMCID:PMC10850029 |
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
|
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
|
| [136] |
|
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
|
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
|
| [153] |
|
| [154] |
|
| [155] |
|
| [156] |
|
| [157] |
|
| [158] |
|
| [159] |
|
| [160] |
|
| [161] |
|
| [162] |
|
| [163] |
Sandau US, Magaña SM, Costa J, et al.; International Society for Extracellular Vesicles Cerebrospinal Fluid Task Force. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies.J Extracell Vesicles2024;13:e12397 PMCID:PMC10756860 |
| [164] |
|
| [165] |
|
| [166] |
|
| [167] |
|
| [168] |
|
| [169] |
|
| [170] |
|
| [171] |
|
| [172] |
|
| [173] |
|
| [174] |
|
| [175] |
|
| [176] |
|
| [177] |
|
| [178] |
|
| [179] |
|
| [180] |
|
| [181] |
|
| [182] |
|
| [183] |
|
| [184] |
|
| [185] |
|
| [186] |
|
| [187] |
|
| [188] |
|
| [189] |
|
| [190] |
|
| [191] |
|
| [192] |
|
| [193] |
|
| [194] |
|
| [195] |
|
| [196] |
|
| [197] |
|
| [198] |
|
| [199] |
|
| [200] |
|
| [201] |
|
| [202] |
|
| [203] |
|
| [204] |
|
| [205] |
|
| [206] |
|
| [207] |
|
| [208] |
|
| [209] |
|
| [210] |
|
| [211] |
|
| [212] |
|
| [213] |
|
| [214] |
|
| [215] |
|
| [216] |
|
| [217] |
|
| [218] |
|
| [219] |
|
| [220] |
|
| [221] |
|
| [222] |
|
| [223] |
|
| [224] |
|
| [225] |
|
| [226] |
|
| [227] |
|
| [228] |
|
| [229] |
|
| [230] |
|
| [231] |
|
| [232] |
|
| [233] |
|
| [234] |
|
| [235] |
|
| [236] |
|
| [237] |
|
| [238] |
|
| [239] |
|
| [240] |
Groot Kormelink T, Arkesteijn GJ, Nauwelaers FA, van den Engh G, Nolte-'t Hoen EN, Wauben MH. Prerequisites for the analysis and sorting of extracellular vesicle subpopulations by high-resolution flow cytometry.Cytometry A2016;89:135-47 |
| [241] |
|
| [242] |
|
| [243] |
|
| [244] |
|
| [245] |
|
| [246] |
|
| [247] |
|
| [248] |
|
| [249] |
|
| [250] |
|
| [251] |
|
| [252] |
|
| [253] |
|
| [254] |
|
| [255] |
|
| [256] |
|
| [257] |
|
| [258] |
Thermo Fisher Scientific. NanoDrop spectrophotometer resources. Available from: https://www.thermofisher.com/de/de/home/industrial/spectroscopy-elemental-isotope-analysis/molecular-spectroscopy/uv-vis-spectrophotometry/instruments/nanodrop/resources.html#Documents-NanoDrop-Eight-Spectrophotometer. [Last accessed on 28 May 2026] |
| [259] |
Thermo Fisher Scientific. NanoDrop micro-UV/Vis spectrophotometer - NanoDrop Eight - User Guide. Available from: https://documents.thermofisher.com/TFS-Assets/MSD/Product-Guides/M020-nanodrop-eight-spectrophotometer-user-guide.pdf. [Last accessed on 28 May 2026] |
| [260] |
|
| [261] |
|
| [262] |
|
| [263] |
|
| [264] |
|
| [265] |
caRNAge. Comprehensive analysis of small RNA gene expression. Available from: https://www.mls.ls.tum.de/physio/forschung/carnage/. [Last accessed on 28 May 2026] |
| [266] |
|
| [267] |
|
| [268] |
|
| [269] |
|
| [270] |
|
| [271] |
|
| [272] |
|
| [273] |
|
| [274] |
|
| [275] |
|
| [276] |
|
| [277] |
|
| [278] |
|
| [279] |
|
| [280] |
|
| [281] |
dMIQE Group; Huggett JF. The digital MIQE guidelines update: minimum information for publication of quantitative digital PCR experiments for 2020.Clin Chem2020;66:1012-29 |
| [282] |
|
| [283] |
|
| [284] |
|
| [285] |
|
| [286] |
|
| [287] |
|
| [288] |
|
| [289] |
|
| [290] |
Van Deun J, Mestdagh P, Agostinis P, et al.; EV-TRACK Consortium. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.Nat Methods2017;14:228-32 |
| [291] |
|
| [292] |
|
| [293] |
|
| [294] |
|
| [295] |
|
| [296] |
|
| [297] |
|
| [298] |
ISEV. Scientific Reproducibility Task Forces. Available from: https://www.isev.org/task-forces. [Last accessed on 28 May 2026] |
| [299] |
|
| [300] |
|
| [301] |
|
| [302] |
|
| [303] |
|
| [304] |
|
| [305] |
|
| [306] |
|
| [307] |
|
| [308] |
|
| [309] |
|
| [310] |
|
| [311] |
|
| [312] |
|
| [313] |
|
| [314] |
|
| [315] |
|
| [316] |
|
| [317] |
|
| [318] |
|
| [319] |
|
| [320] |
|
| [321] |
|
| [322] |
|
| [323] |
MiRXES. The genesis of GASTROClear. 2021. Available from: https://mirxes.com/the-genesis-of-gastroclear/. [Last accessed on 28 May 2026] |
| [324] |
MiRXES. Mirxes receives FDA’s Breakthrough Device Designation for GASTROClear to advance blood-based cancer early detection. 2023. Available from: https://mirxes.com/mirxes-receives-fdas-breakthrough-device-designation-for-gastroclear-to-advance-blood-based-cancer-early-detection/. [Last accessed on 28 May 2026] |
| [325] |
|
| [326] |
|
| [327] |
|
| [328] |
|
| [329] |
|
| [330] |
|
| [331] |
|
| [332] |
|
| [333] |
|
| [334] |
|
| [335] |
|
| [336] |
|
| [337] |
|
| [338] |
|
| [339] |
|
| [340] |
|
| [341] |
|
| [342] |
|
| [343] |
|
| [344] |
|
| [345] |
|
| [346] |
|
| [347] |
|
| [348] |
|
| [349] |
|
| [350] |
|
| [351] |
|
| [352] |
|
| [353] |
|
| [354] |
|
| [355] |
|
| [356] |
|
| [357] |
|
| [358] |
|
| [359] |
|
| [360] |
|
| [361] |
|
| [362] |
|
| [363] |
|
/
| 〈 |
|
〉 |